Robert J. Mathvink

Statistics

Publications

Citations

1.2K

H-Index

Active since

1988

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

Robert J. Mathvink is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacology, medicinal chemistry, and drug discovery.

Publications per year

1988–2011

Publications

Acyl radicals: intermolecular and intramolecular alkene addition reactions

Dale L. Boger, Robert J. Mathvink · The Journal of Organic Chemistry · 1992 · 217 citations

Natural Sciences, Chemistry, Analytical Chemistry +8

(2S,3S)-3-Amino-4-(3,3-difluoropyrrolidin-1-yl)-N,N-dimethyl-4-oxo-2-(4-[1,2,4]triazolo[1,5-a]- pyridin-6-ylphenyl)butanamide: A Selective α-Amino Amide Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes

Scott D. Edmondson, Anthony Mastracchio, Robert J. Mathvink et al. · Journal of Medicinal Chemistry · 2006 · 121 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +16

A selective human beta3 adrenergic receptor agonist increases metabolic rate in rhesus monkeys.

M. H. FISHER, A Amend, Tom Bach et al. · Journal of Clinical Investigation · 1998 · 115 citations · Full text

Life Sciences, Pharmacology, Physiology +17

Acyl radicals: functionalized free radicals for intramolecular cyclization reactions

Dale L. Boger, Robert J. Mathvink · The Journal of Organic Chemistry · 1988 · 81 citations

Natural Sciences, Chemistry, Analytical Chemistry +5

Tandem free-radical alkene addition reactions of acyl radicals

Dale L. Boger, Robert J. Mathvink · Journal of the American Chemical Society · 1990 · 71 citations

Natural Sciences, Chemistry, Analytical Chemistry +8

1–5 of 21